Wikisage, the free encyclopedia of the second generation, is digital heritage
Topiramate: Difference between revisions
Jump to navigation
Jump to search
m (→[ATC]]) |
No edit summary |
||
| Line 2: | Line 2: | ||
Qudexy<sup>TM</sup> is an [[XR-topiramate|extended release]] form of topiramate and could be use in patient unable to swalow intact capsules <ref>http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract</ref> | Qudexy<sup>TM</sup> is an [[XR-topiramate|extended release]] form of topiramate and could be use in patient unable to swalow intact capsules <ref>http://www.epilepsybehavior.com/article/S1525-5050(16)00057-3/abstract</ref> | ||
<gallery> | <gallery> | ||
File:Under_construction_icon.png | File:Under_construction_icon.png | ||
</gallery> | </gallery> | ||
| Line 20: | Line 19: | ||
==[[ATC]]== | ==[[ATC]]== | ||
<gallery>File:Topiramate_3D.png</gallery> | |||
<ref>https://www.whocc.no/atc_ddd_index/?code=N03AX11</ref> | <ref>https://www.whocc.no/atc_ddd_index/?code=N03AX11</ref> | ||
Revision as of 15:19, 21 May 2019
topiramate compared to phenobarbital result better effect on, both partial, generalized [1] QudexyTM is an extended release form of topiramate and could be use in patient unable to swalow intact capsules [2]
Links
Phentermine and topiramate for the management of obesity: a review
Topiramate-induced periodic limb movement disorders in a patient affected by focal epilepsy
